# The COlchicine HypERtENsion Trial

Study · id `cardio:ct-nct04916522` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04916522](<https://clinicaltrials.gov/study/NCT04916522>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04916522

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: High blood pressure; Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 150 participants.

## Technical summary

Registry record NCT04916522. Randomized; double masking; primary purpose treatment. Start 2021-08-10 (actual); primary completion 2026-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT04916522, source copy `cardio:ctgov-nct04916522-2025-12-22`, retrieved 2026-10-26)
- Started: 2021-08-10 (actual) (ClinicalTrials.gov record NCT04916522, source copy `cardio:ctgov-nct04916522-2025-12-22`, retrieved 2026-10-26)
- Primary completion: 2026-01 (anticipated) (ClinicalTrials.gov record NCT04916522, source copy `cardio:ctgov-nct04916522-2025-12-22`, retrieved 2026-10-26)
- Completion: 2026-01 (anticipated) (ClinicalTrials.gov record NCT04916522, source copy `cardio:ctgov-nct04916522-2025-12-22`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT04916522, source copy `cardio:ctgov-nct04916522-2025-12-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04916522-2025-12-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: The COlchicine HypERtENsion Trial
- Acronym: COHERENT
- Condition: Hypertension
- Intervention (Drug): Colchicine
- Intervention (Drug): Placebo
- Lead sponsor: Herlev and Gentofte Hospital
- Lead sponsor class: OTHER
- Collaborator: University of Copenhagen
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Colchicine (`cardio:colchicine`)
- Registry lists this organization as the lead sponsor: Herlev and Gentofte Hospital (`cardio:org-herlev-and-gentofte-hospital`)
- Registry lists this organization as a collaborator: University of Copenhagen (`cardio:org-university-of-copenhagen`)

## Provenance

Content hash: 17dbe9925798aa2c5fbac588212e513c570a6287b9bba79b117af4379e91ca1f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
